(1)What are the reasons that (a) the SA Health Products Regulatory Authority stakeholder engagement committees are controlled by pharmaceutical companies, such as Stavros as the chair of Industry Technical Group and (b) there are no public representatives in the specified forums;
(2) whether the forums are also utilised as private regulatory consultations for big pharmacies; if not, what is the position in this regard; if so, what are the relevant details?